<DOC>
	<DOCNO>NCT02715583</DOCNO>
	<brief_summary>Patients castrate resistant prostate cancer ( CRPCA ) osseous metastatic disease plan undergo Ra-223 therapy may eligible study . Positron emission tomography ( PET/CT ) imaging use investigational radiotracer [ 11C ] acetate . Imaging occur prior Ra-223 therapy 2 cycle , addition standard care 99mTcMDP bone scan baseline research 99mTc-MDP bone scan post-therapy</brief_summary>
	<brief_title>C-Acetate PET/CT Imaging Evaluate Treatment Changes Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria least 18 year age History biopsy proven clinically documented castrate resistant prostate cancer metastatic bone assess medical record review . Patients select Ra223 dichloride therapy treatment bone metastasis treat physician . Participants must inform investigational nature study provide write informed consent accordance institutional federal guideline prior studyspecific procedure . Not current androgen deprivation therapy plan withdrawal androgen deprivation therapy Cytotoxic chemotherapy within 4 week prior study enrollment Systemic radioisotope therapy within 24 week prior study enrollment Eminent establish cord compression assess medical record review History hemibody external radiotherapy assess medical record review Inability tolerate imaging procedure opinion investigator treat physician Serious unstable medical psychological comorbidities , opinion investigator , would compromise subject 's safety successful participation study . Documented visceral metastasis current lymphadenopathy &gt; 3 cm standard imaging ( e.g . MRI , CT , ultrasound , FDG PET/CT ) Only individual ( age 18 ) understand give inform consent eligible participate study . Individuals consider mentally disabled recruit study . All subject must able give informed consent . We use specific method assess decisional capacity . Economically disadvantaged person vulnerable undue influence , study offer compensation . All individual tell choice regard study participation way change access clinical care . This negate undue influence coercion . Women , child , fetus , neonate , prisoner include research study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>